Effects of oleanolic acid and maslinic acid on hyperlipidemia

Drug Development Research

Volumn 68, Issue 5, 2007, Pages 261-266

  Liu, Jun ^a   Sun, Hongbin ^a   Wang, Xiaofen ^a   Mu, Dongyan ^a   Liao, Hong ^a   Zhang, Luyong ^a  

^a CHINA PHARMACEUTICAL UNIVERSITY   (China)

Author keywords

Hyperlipidemia; Lipid metabolism; Marker enzymes; Pentacyclic triterpenes

Indexed keywords

CHOLESTEROL; CHOLESTEROL ACYLTRANSFERASE; GLYCOGEN; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LIVER ENZYME; LOW DENSITY LIPOPROTEIN CHOLESTEROL; MASLINIC ACID; MESSENGER RNA; OLEANOLIC ACID; TRIACYLGLYCEROL;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL DAMAGE; CHOLESTEROL DIET; CONTROLLED STUDY; ENZYME ACTIVITY; FEEDING; GENE EXPRESSION; GLYCOGEN LIVER LEVEL; HISTOLOGY; HYPERLIPIDEMIA; INTESTINE ABSORPTION; LIPID STORAGE; MALE; NONHUMAN; RAT;

EID: 36849022040     PISSN: 02724391     EISSN: 10982299     Source Type: Journal    
DOI: 10.1002/ddr.20187     Document Type: Article

References (16)

1. Assy N, Kaita K, Mymin D, Levy C, Rosser B, Minuk G. 2000. Fatty infiltration of liver in hyperlipidemic patients. Dig Dis Sci 45:1929-1934.
2. Bhatnagar D. 1998. Lipid-lowing drugs in the management of hyperlipidaemia. Pharmacol Ther 79:205-213.
3. Chen J, Liu L, Zhang LY, Wu GZ, Hua WY, Wu XM, Sun HB. 2006a. Pentacyclic triterpenes. Part 3. Synthesis and biological evaluation of oleanolic acid derivatives as novel inhibitors of glycogen phosphorylase. Bioorg Med Chem Lett 16:2915-2919.
4. Chen J, Liu J, Gong YC, Zhang LY, Hua WT, Sun HB. 2006b. Synthesis and biological evaluation of nrosolic acid derivatives as novel inhibitors of glycogen phosphorylase. J China Pharm Univ 37:397-402.
5. Dzubak P, Hajduch M, Vydra D, Hustova A, Kvasnica M, Biedermann D, Markova L, Urbane M, Sarek J. 2006. Pharmacological activities of natural triterpenoids and their therapeutic implications. Nat Prod Rep 23:394-411.
6. Frick MH, Elo O, Haapa K, Heinonen OP, Heinsalmi P, Helo P, Huttunen JK, Kaitaniemi P, Koskinen P, Manninen V. 1987. Helsinki heart study: primary-prevention trial with gemfibrozil in middle-aged men with dyslipidemia. Safety of treatment changes in risk factors, and incidence of coronary heart disease. N Engl J Med 317:1237-1245.
7. Gupta PP, Tandon HD, Ramalingaswami V. 1976. Cirrhosis of the liver in rabbits induced by a high cholesterol diet - an experimental model. Indian J Med Res 64:1516-1526.
8. Handel EV. 1965. Estimation of glycogen in small amounts of tissue. Anal Biochem 17:256-265.
9. Kasturen K, Tamura T, Arashiro R, Takata K, Matsuura T, Niikaawa N, Ohta T. 2001. Structure of the human acyl-CoA: cholesterol acyltransferase-2 (ACAT-2) gene and its relation to dyslipidemia. Biochim Biophys Acta 1531:230-240.
10. King J. 1965. In: Practical clinical enzymology. Van D, editor. London: Nostrand. p 83-208.
11. Lee WS, Im KR, Park YD, Sung ND, Jeong TS. 2006. Human ACAT-1 and ACAT-2 inhibitory activities of pentacyclic triterpenes from the leaves of Lycopus lucidus TURCZ. Biol Pharm Bull 29:382-384.
12. Saleh J, Sniderman AD, Cianflone K. 1999. Regulation of plasma fatty acid metabolism. Clin Chim Acta 286:163-180.
13. Spady DK, Dietschy JM. 1985. Interaction of dietary cholesterol and triglycerides in the regulation of hepatic low density lipoprotein transport in the hamster. Proc Natl Acad Sci USA 82:4526-4530.
14. Turpeinen O. 1979. Effect of cholesterol-lowing diet on mortality from coronary heart disease and other causes. Circulation 59:1-7.
15. Wen XA, Sun HB, Liu J, Wu GZ, Zhang LY, Wu XM, Ni PZ. 2005. Bioorg Med Chem Lett 15:4944-4948.
16. Wen XA, Zhang P, Liu J, Zhang LY, Wu XM, Ni PZ, Sun HB. 2006. Bioorg Med Chem Lett 16:722-726.